Advanced Tear Diagnostics
Birmingham, US · Delaware LLC
Founders & leadership
AP
Andrew PenmanExecutive
JB
Jeffrey BusbyExecutive
CV
Catalina ValenciaExecutive
GW
Gene WahnefriedExecutive
PY
Pierce YoungbarExecutive
MS
Marcus SmithExecutive
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 2 rounds · 2012–2014
▶$385KraisedOct 2016 · 10 investors · BiotechnologyRule 506(b)
▶$385KraisedOct 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew PenmanExecutive Officer
- Jeffrey BusbyExecutive Officer
- Catalina ValenciaExecutive Officer
- Gene WahnefriedExecutive Officer
- Pierce YoungbarExecutive Officer
- Marcus SmithExecutive Officer, Director
- Offering amount
- $385K
- Amount sold
- $385K
- Minimum investment
- $15K
- First sale
- Mar 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedSep 2016 · 18 investors · BiotechnologyRule 506(b)
▶$1.4MraisedSep 2016 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey BusbyExecutive Officer
- Marcus SmithExecutive Officer, Director
- Pierce YoungbarExecutive Officer
- Andrew PenmanExecutive Officer
- Catalina ValenciaExecutive Officer
- Gene WahnefriedExecutive Officer
- Offering amount
- $7M
- Amount sold
- $1.4M
- Minimum investment
- $25K
- First sale
- Jan 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Advanced Tear Diagnostics raised?
- Advanced Tear Diagnostics has disclosed $1.8M raised across 2 rounds.
- Where is Advanced Tear Diagnostics headquartered?
- Advanced Tear Diagnostics is headquartered in Birmingham, US.